Skip to content
← Back to this collection

PUBLICATIONS · 30501871

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2018 Dec
First author
Biondi A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Biondi A
      type
      Author
    2. name
      Gandemer V
      type
      Author
    3. name
      De Lorenzo P
      type
      Author
    4. name
      Cario G
      type
      Author
    5. name
      Campbell M
      type
      Author
    6. name
      Castor A
      type
      Author
    7. name
      Pieters R
      type
      Author
    8. name
      Baruchel A
      type
      Author
    9. name
      Vora A
      type
      Author
    10. name
      Leoni V
      type
      Author
    11. name
      Stary J
      type
      Author
    12. name
      Escherich G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Biondi A
      type
      Author
    2. name
      Gandemer V
      type
      Author
    3. name
      De Lorenzo P
      type
      Author
    4. name
      Cario G
      type
      Author
    5. name
      Campbell M
      type
      Author
    6. name
      Castor A
      type
      Author
    7. name
      Pieters R
      type
      Author
    8. name
      Baruchel A
      type
      Author
    9. name
      Vora A
      type
      Author
    10. name
      Leoni V
      type
      Author
    11. name
      Stary J
      type
      Author
    12. name
      Escherich G
      type
      Author
    bibliography ids
    1. nci-bib-f30a4f5aaddba9c865e7de11
    book metadata
    content sha256
    fd0fc698fe7b90b318d3c7b9fc0160f67614af0966e2e5a64fdf0f56c7713a03
    document type
    citation
    dois
    1. 10.1016/S2352-3026(18)30173-X
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30501871
    immutable id
    pubmed:30501871@fd0fc698fe7b90b318d3c7b9fc0160f67614af0966e2e5a64fdf0f56c7713a03
    journal
    abbreviation
    Lancet Haematol
    issn electronic
    2352-3026
    issn print
    Source null
    issue
    12
    name
    The Lancet. Haematology
    nlm unique id
    101643584
    pages
    e641-e652
    volume
    5
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30501871
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      b24a697c0e65d8847e18696a86cd54b81678a472078ab811c5485a7691e33093
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Dec
      precision
      month
      year
      2018
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30501871/
      title
      Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

      Preserved source evidence · Not medical advice